Malcolm D. Mason

机构：Cardiff University · ORCID：0000-0003-1505-2869

发表论文 442 篇 · 总被引 48443 次 · h-index 94

代表论文

• Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol (2023 · The Lancet Oncology · 被引 114)
• Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality (2024 · JAMA · 被引 110)
• Aspirin and cancer treatment: systematic reviews and meta-analyses of evidence: for and against (2023 · British Journal of Cancer · 被引 51)
• Impact of Epithelial Histological Types, Subtypes, and Growth Patterns on Oncological Outcomes for Patients with Nonmetastatic Prostate Cancer Treated with Curative Intent: A Systematic Review (2023 · European Urology · 被引 31)
• Correction: YangZheng XiaoJi exerts anti-tumour growth effects by antagonising the effects of HGF and its receptor, cMET, in human lung cancer cells (2024 · Journal of Translational Medicine · 被引 1)
• RWD123 Machine Learning (ML) Applied to Real-World Data to Guide Prescription of Immune-Therapies in Metastatic Melanoma: A Pilot Study (2023 · Value in Health)